| Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma X Wei, F Huang, Y Wei, H Jing, M Xie, X Hao, R Feng Leukemia research 38 (6), 694-698, 2014 | 50 | 2014 |
| Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma X Hao, Y Wei, X Wei, L Zhou, Q Wei, Y Zhang, W Huang, R Feng Oncotarget 8 (44), 76740, 2017 | 45 | 2017 |
| Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP Q Zhou, Y Wei, F Huang, X Wei, Q Wei, X Hao, Y Zhang, R Feng International journal of hematology 104, 485-490, 2016 | 37 | 2016 |
| The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma X Hao, X Wei, F Huang, Y Wei, H Zeng, L Xu, Q Zhou, R Feng PloS one 10 (5), e0126615, 2015 | 33 | 2015 |
| PAK kinase inhibition has therapeutic activity in novel preclinical models of adult T-cell leukemia/lymphoma EY Chung, Y Mai, UA Shah, Y Wei, E Ishida, K Kataoka, X Ren, ... Clinical Cancer Research 25 (12), 3589-3601, 2019 | 24 | 2019 |
| The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression X Wei, M Xu, Y Wei, F Huang, T Zhao, X Li, R Feng, BH Ye Journal of Hematology & Oncology 7, 1-3, 2014 | 21 | 2014 |
| Consecutive hypoalbuminemia predicts inferior outcome in patients with diffuse large B-cell lymphoma X Wei, J Zheng, Z Zhang, Q Liu, M Zhan, W Huang, J Chen, Q Wei, Y Wei, ... Frontiers in Oncology 10, 610681, 2021 | 19 | 2021 |
| The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma JL Song, XL Wei, YK Zhang, XX Hao, WM Huang, Q Wei, YQ Wei, R Feng Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi 39 (9), 739-744, 2018 | 17 | 2018 |
| Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma Y Wei, X Wei, W Huang, J Song, J Zheng, H Zeng, J Liu, M Zhan, Q Wei, ... International Journal of Hematology 111, 681-685, 2020 | 15 | 2020 |
| Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments X Wei, Y Wei Annals of Hematology 102 (5), 995-1009, 2023 | 14 | 2023 |
| Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma X Wei, Y Wei, F Huang, H Jing, M Xie, X Hao, R Feng Leukemia & Lymphoma 56 (5), 1261-1265, 2015 | 10 | 2015 |
| The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP X Wei, X Hao, L Zhou, Q Wei, Y Zhang, W Huang, J Song, R Feng, Y Wei Scientific Reports 7 (1), 13592, 2017 | 6 | 2017 |
| Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow … F Huang, X Zeng, Z Fan, N Xu, S Yu, L Xuan, H Liu, H Jin, R Lin, P Shi, ... Transplantation and Cellular Therapy 28 (12), 849. e1-849. e8, 2022 | 5 | 2022 |
| Partial immunoparesis contributes to risk of early infections in patients with multiple myeloma W Huang, X Wei, Q Wei, Y Wei, R Feng Translational Cancer Research 10 (12), 5258, 2021 | 5 | 2021 |
| RETRACTED ARTICLE: LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p H Zeng, Y Wei, X Wei, R Feng Cancer Management and Research, 3589-3599, 2021 | 5 | 2021 |
| HIF-1a Regulating the Chemoresistance By Upregulating the Expression of xCT and GCLM in the Diffuse Large B Cell Lymphoma Y Wei, H Zeng, X Wei, W Huang, J Song, J Zheng, R Feng Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 4 | 2019 |
| Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma D Xiong, X Wei, W Huang, J Zheng, R Feng Aging (Albany NY) 16 (2), 1049, 2024 | 3 | 2024 |
| Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma W Huang, X Wei, Y Wei, R Feng DNA and Cell Biology 37 (12), 947-952, 2018 | 3 | 2018 |
| Low serum albumin predicts inferior outcome in patients with diffuse large B-cell lymphoma X Wei, Y Wei, W Huang, J Song, Q Wei, R Feng Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 5237 …, 2017 | 3 | 2017 |
| NCCN-IPI is superior to aaIPI and IPI in predicting survival of DLBCL in the rituximab era Y Wei, Y Zhang, X Hao, X Wei, W Huang, R Feng Blood, The Journal of the American Society of Hematology 128 (22), 1872-1872, 2016 | 3 | 2016 |
